Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats

Takanari Kitazono, Donald D. Heistad, Frank M. Faraci

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We tested the hypothesis that responses of the basilar artery to selective activation of endothelin-B receptors are altered during chronic hypertension. Using a cranial window in anesthetized rats, we examined responses of the basilar artery to a selective endothelin-B receptor agonist, IRL 1620, in stroke-prone spontaneously hypertensive rats (SHRSP). Under control conditions, baseline basilar artery diameter was smaller in SHRSP (196±8 μm [mean±SEM]) than in normotensive Wistar-Kyoto rats (WKY) (245±9 μm, P<.05). Topical application of IRL 1620 (10-8 mol/L) dilated the basilar artery by 27±5% in WKY and 56±4% in SHRSP (P<.05). Dilatation of the basilar artery in response to sodium nitroprusside was similar in WKY and SHRSP. In contrast, acetylcholine-induced vasodilatation in SHRSP was markedly impaired. N(G)-Nitro-L-arginine methyl ester and N(G)-nitro-L- arginine, inhibitors of nitric oxide synthase, inhibited IRL 1620-induced vasodilatation in WKY. Neither N(G)-nitro-L-arginine methyl ester nor indomethacin attenuated vasodilatation produced by IRL 1620 in SHRSP. The major finding is that dilator responses of the basilar artery to selective activation of endothelin-B receptors are paradoxically enhanced in SHRSP compared with WKY. Dilator responses of the basilar artery to endothelin-B receptor activation are mediated by endothelium-derived relaxing factor in WKY. In contrast, responses to activation of endothelin receptors in SHRSP do not depend on the production of nitric oxide or prostanoids.

Original languageEnglish
Pages (from-to)490-494
Number of pages5
JournalHypertension
Volume25
Issue number4 I
DOIs
Publication statusPublished - Jan 1 1995
Externally publishedYes

Fingerprint

Endothelin B Receptors
Basilar Artery
Inbred SHR Rats
Inbred WKY Rats
Stroke
Vasodilation
NG-Nitroarginine Methyl Ester
Endothelium-Dependent Relaxing Factors
Endothelin Receptors
Nitroprusside
Nitric Oxide Synthase
Indomethacin
Acetylcholine
Prostaglandins
Arginine
Dilatation
Nitric Oxide
Hypertension
IRL 1620

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats. / Kitazono, Takanari; Heistad, Donald D.; Faraci, Frank M.

In: Hypertension, Vol. 25, No. 4 I, 01.01.1995, p. 490-494.

Research output: Contribution to journalArticle

@article{d1d3766c9c6e45989b6d5735e922fc8e,
title = "Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats",
abstract = "We tested the hypothesis that responses of the basilar artery to selective activation of endothelin-B receptors are altered during chronic hypertension. Using a cranial window in anesthetized rats, we examined responses of the basilar artery to a selective endothelin-B receptor agonist, IRL 1620, in stroke-prone spontaneously hypertensive rats (SHRSP). Under control conditions, baseline basilar artery diameter was smaller in SHRSP (196±8 μm [mean±SEM]) than in normotensive Wistar-Kyoto rats (WKY) (245±9 μm, P<.05). Topical application of IRL 1620 (10-8 mol/L) dilated the basilar artery by 27±5{\%} in WKY and 56±4{\%} in SHRSP (P<.05). Dilatation of the basilar artery in response to sodium nitroprusside was similar in WKY and SHRSP. In contrast, acetylcholine-induced vasodilatation in SHRSP was markedly impaired. N(G)-Nitro-L-arginine methyl ester and N(G)-nitro-L- arginine, inhibitors of nitric oxide synthase, inhibited IRL 1620-induced vasodilatation in WKY. Neither N(G)-nitro-L-arginine methyl ester nor indomethacin attenuated vasodilatation produced by IRL 1620 in SHRSP. The major finding is that dilator responses of the basilar artery to selective activation of endothelin-B receptors are paradoxically enhanced in SHRSP compared with WKY. Dilator responses of the basilar artery to endothelin-B receptor activation are mediated by endothelium-derived relaxing factor in WKY. In contrast, responses to activation of endothelin receptors in SHRSP do not depend on the production of nitric oxide or prostanoids.",
author = "Takanari Kitazono and Heistad, {Donald D.} and Faraci, {Frank M.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1161/01.HYP.25.4.490",
language = "English",
volume = "25",
pages = "490--494",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4 I",

}

TY - JOUR

T1 - Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats

AU - Kitazono, Takanari

AU - Heistad, Donald D.

AU - Faraci, Frank M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We tested the hypothesis that responses of the basilar artery to selective activation of endothelin-B receptors are altered during chronic hypertension. Using a cranial window in anesthetized rats, we examined responses of the basilar artery to a selective endothelin-B receptor agonist, IRL 1620, in stroke-prone spontaneously hypertensive rats (SHRSP). Under control conditions, baseline basilar artery diameter was smaller in SHRSP (196±8 μm [mean±SEM]) than in normotensive Wistar-Kyoto rats (WKY) (245±9 μm, P<.05). Topical application of IRL 1620 (10-8 mol/L) dilated the basilar artery by 27±5% in WKY and 56±4% in SHRSP (P<.05). Dilatation of the basilar artery in response to sodium nitroprusside was similar in WKY and SHRSP. In contrast, acetylcholine-induced vasodilatation in SHRSP was markedly impaired. N(G)-Nitro-L-arginine methyl ester and N(G)-nitro-L- arginine, inhibitors of nitric oxide synthase, inhibited IRL 1620-induced vasodilatation in WKY. Neither N(G)-nitro-L-arginine methyl ester nor indomethacin attenuated vasodilatation produced by IRL 1620 in SHRSP. The major finding is that dilator responses of the basilar artery to selective activation of endothelin-B receptors are paradoxically enhanced in SHRSP compared with WKY. Dilator responses of the basilar artery to endothelin-B receptor activation are mediated by endothelium-derived relaxing factor in WKY. In contrast, responses to activation of endothelin receptors in SHRSP do not depend on the production of nitric oxide or prostanoids.

AB - We tested the hypothesis that responses of the basilar artery to selective activation of endothelin-B receptors are altered during chronic hypertension. Using a cranial window in anesthetized rats, we examined responses of the basilar artery to a selective endothelin-B receptor agonist, IRL 1620, in stroke-prone spontaneously hypertensive rats (SHRSP). Under control conditions, baseline basilar artery diameter was smaller in SHRSP (196±8 μm [mean±SEM]) than in normotensive Wistar-Kyoto rats (WKY) (245±9 μm, P<.05). Topical application of IRL 1620 (10-8 mol/L) dilated the basilar artery by 27±5% in WKY and 56±4% in SHRSP (P<.05). Dilatation of the basilar artery in response to sodium nitroprusside was similar in WKY and SHRSP. In contrast, acetylcholine-induced vasodilatation in SHRSP was markedly impaired. N(G)-Nitro-L-arginine methyl ester and N(G)-nitro-L- arginine, inhibitors of nitric oxide synthase, inhibited IRL 1620-induced vasodilatation in WKY. Neither N(G)-nitro-L-arginine methyl ester nor indomethacin attenuated vasodilatation produced by IRL 1620 in SHRSP. The major finding is that dilator responses of the basilar artery to selective activation of endothelin-B receptors are paradoxically enhanced in SHRSP compared with WKY. Dilator responses of the basilar artery to endothelin-B receptor activation are mediated by endothelium-derived relaxing factor in WKY. In contrast, responses to activation of endothelin receptors in SHRSP do not depend on the production of nitric oxide or prostanoids.

UR - http://www.scopus.com/inward/record.url?scp=0028931277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028931277&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.25.4.490

DO - 10.1161/01.HYP.25.4.490

M3 - Article

C2 - 7721388

AN - SCOPUS:0028931277

VL - 25

SP - 490

EP - 494

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4 I

ER -